Biomarin Pharmaceutical
Price & Volume
Stats
See more52W Range | $50.76-$66.28 |
Market Cap | $10.4B |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $3.2B |
Revenue Growth (YoY) | 17% |
Gross Profit (12 Mos) | $1.7B |
Diluted EPS | $1.80 |
News
See moreYahoo Finance • 7 days ago
Notable healthcare headlines for the week: Apellis, Centessa, and UnitedHealth in focus
Yahoo Finance • 13 days ago
BioMarin Pharmaceutical Inc. (BMRN) Rated Overweight at Wells Fargo Despite Voxzogo Phase 2 Study Discontinuations
Yahoo Finance • 23 days ago
Biotech Stock Up 372% Gets Sold as New Pick Rises 40% in 2026
Yahoo Finance • 23 days ago
This Biotech Stock Has Surged 250% in a Year as One Investor Discloses $10 Million New Position
About
CEO | Mr. Alexander Hardy |
CFO | Mr. Brian R. Mueller CPA |
Address | 770 Lindaro Street, San Rafael, CA, United States, 94901 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 3,221 |
